| Filed On | Filing |
|---|---|
| 12 Nov 2026 | 10-Q |
| 12 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +3 more
CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. IN THIS EXHIBIT, “[***]” INDICATES WHERE SUCH INFORMATION HAS BEEN OMITTED. |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
Cash, cash equivalents, and marketable securities as of June 30, 2026 expected to support planned operations into Q3 2028. |
| 29 Jul 2026 | SCHEDULE 13G |
| 02 Jul 2026 |
Form 4: Bradsher Neal C, Director
Granted 125,000 OPTION TO PURCHASE COMMON SHARES |
| 02 Jul 2026 |
Form 4: Jayasuriya Anula, Director
Granted 125,000 Stock Option (Right to Buy) |
| 02 Jul 2026 |
Form 4: Mulroy Michael H., Director
Granted 125,000 Stock Option (Right to Buy) |
| 02 Jul 2026 |
Form 4: Andrews Deborah J, Director
Granted 125,000 Stock Option (Right to Buy) |
| 02 Jul 2026 |
Form 4: Russell Angus C., Director
Granted 125,000 Stock Option (Right to Buy) |
| 02 Jul 2026 |
Form 4: Amin Dipti, Director
Granted 125,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders; Other Events
The annual meeting of shareholders (the “Annual Meeting”) of Lineage Cell Therapeutics, Inc. (the “Company”), was held on June 10, 2026 and involved the election of directors of the Company and two other matters voted upon by the Company... |
| 12 May 2026 | 10-Q |
| 12 May 2026 |
8-K: Results of Operations and Financial Condition
CARLSBAD, CA – May 12, 2026 - Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today reported its ... |
| 29 Apr 2026 | ARS |
| 29 Apr 2026 | DEFA14A |
| 29 Apr 2026 |
Proxy statement: annual meeting on June 10, 2026
CEO pay $2.1M, down 17% · say-on-pay vote |
| 23 Mar 2026 | EFFECT |
| 19 Mar 2026 | CORRESP |
| 16 Mar 2026 | UPLOAD |
Loading...